Who backs Alentis Therapeutics?
21 investors| Investor | Type |
|---|---|
| Bpifrance | Other |
| RA Capital Management | Asset manager |
| High-Tech Gründerfonds | Venture capital |
| OrbiMed | Growth equity |
| Kinled Holding | Family office |
| Novo Holdings | Other |
| Innosuisse | Other |
| Catalio Capital Management | Venture capital |
| Morningside Group | Venture capital |
| Frazier Healthcare Partners | Venture capital |
| + 11 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Alentis Therapeutics investors
21 investors are on record for Alentis Therapeutics, including Bpifrance, RA Capital Management, High-Tech Gründerfonds and OrbiMed. By type, the record holds 5 venture capital firms and 1 family office. The Series D in Nov 2024 drew 12 investors.
Free account
More of Alentis Therapeutics with a free account
- ·The complete investor list: 21 names
- ·Watch Alentis Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 21 firms already write checks for companies like Alentis Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View